|

The latest news from Chinese pharma and biotech, including BMS’ attempts to pull out of its Abraxane supply deal…

Save Share

Saudi Arabia’s ambitious Vision 2030 economic transformation plan aims at transitioning the Middle East’s…

Save Share

In a notable first, following successful pilot immunisation programmes in Ghana, Kenya and Malawi, the World Health…

Save Share

The latest news from Indian pharm and healthcare, including Piramal Enterprises’ decision to demerge and list its…

Save Share

Shawview Consulting’s Brendan Shaw examines the WHO’s recently released updated Essential Medicines…

Save Share

The National Organization for Rare Disorders (NORD) is set to host its annual Rare Diseases and Orphan Products…

Save Share

The following is an overview from Accestra Consulting* of Part 2 of China’s Center for Drug Evaluation (CDE)’s…

Save Share

PhRMA’s Lori Reilly warns that, as US policymakers seek to reduce drug prices, they must avoid policies that…

Save Share

Saudi Arabia has one of the highest rates of diabetes in the world – over 17 percent of the population are…

Save Share

This piece forms part of InFocus Biotechs to Watch Switzerland 2021, a deep dive into the Swiss biotech ecosystem…

Save Share

Since joining Danish neuroscience specialist Lundbeck as its global CEO in 2018, South African Deborah Dunsire has…

Save Share

Paula Barbosa, head of influenza policy and advocacy at the IFPMA and board member of the #TogetherAgainstFlu…

Save Share